Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2699622rdf:typepubmed:Citationlld:pubmed
pubmed-article:2699622lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:2699622lifeskim:mentionsumls-concept:C0023348lld:lifeskim
pubmed-article:2699622lifeskim:mentionsumls-concept:C0370073lld:lifeskim
pubmed-article:2699622pubmed:issue5-6lld:pubmed
pubmed-article:2699622pubmed:dateCreated1990-6-13lld:pubmed
pubmed-article:2699622pubmed:abstractTextSera from 140 lepromatous leprosy patients (test group) and 120 normal persons, who showed no clinical signs of acute or chronic toxoplasmosis (control group), were studied for the presence of Toxoplasma gondii antibody by indirect hemagglutination and indirect-immunofluorescent antibody tests. Both tests showed a high incidence of Toxoplasma antibody in the test group in comparison with the control group. IgM and IgG classes of antibody responses were observed in both the groups, which signified recent as well as past infections in them.lld:pubmed
pubmed-article:2699622pubmed:languageenglld:pubmed
pubmed-article:2699622pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2699622pubmed:citationSubsetIMlld:pubmed
pubmed-article:2699622pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2699622pubmed:statusMEDLINElld:pubmed
pubmed-article:2699622pubmed:issn0021-5112lld:pubmed
pubmed-article:2699622pubmed:authorpubmed-author:SahaKKlld:pubmed
pubmed-article:2699622pubmed:authorpubmed-author:BhatiaV NVNlld:pubmed
pubmed-article:2699622pubmed:authorpubmed-author:RaoK NKNlld:pubmed
pubmed-article:2699622pubmed:authorpubmed-author:GadeWWlld:pubmed
pubmed-article:2699622pubmed:issnTypePrintlld:pubmed
pubmed-article:2699622pubmed:volume42lld:pubmed
pubmed-article:2699622pubmed:ownerNLMlld:pubmed
pubmed-article:2699622pubmed:authorsCompleteYlld:pubmed
pubmed-article:2699622pubmed:pagination163-8lld:pubmed
pubmed-article:2699622pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:meshHeadingpubmed-meshheading:2699622-...lld:pubmed
pubmed-article:2699622pubmed:articleTitleToxoplasma gondii antibody in patients of lepromatous leprosy.lld:pubmed
pubmed-article:2699622pubmed:affiliationDepartment of Immunology, Vallabhbhai Patel Chest Institute, University of Delhi, India.lld:pubmed
pubmed-article:2699622pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2699622pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed